Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,845 | 444 | 99.5% |
| Education | $31.30 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,221 | 72 | $0 (2024) |
| Lilly USA, LLC | $875.76 | 78 | $0 (2023) |
| Novo Nordisk Inc | $858.87 | 50 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $776.21 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $632.23 | 46 | $0 (2023) |
| Amgen Inc. | $192.72 | 11 | $0 (2023) |
| Astellas Pharma US Inc | $182.12 | 12 | $0 (2022) |
| PFIZER INC. | $166.91 | 12 | $0 (2024) |
| Amarin Pharma Inc. | $157.35 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $153.89 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $715.99 | 41 | ABBVIE INC. ($291.86) |
| 2023 | $682.23 | 42 | AbbVie Inc. ($287.60) |
| 2022 | $569.15 | 36 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($158.77) |
| 2021 | $1,086 | 68 | AbbVie Inc. ($318.09) |
| 2020 | $681.60 | 41 | Lilly USA, LLC ($212.21) |
| 2019 | $962.21 | 64 | AbbVie, Inc. ($181.90) |
| 2018 | $1,099 | 76 | Novo Nordisk Inc ($254.26) |
| 2017 | $1,080 | 81 | Lilly USA, LLC ($197.28) |
All Payment Transactions
449 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.96 | General |
| Category: Cardiovascular | ||||||
| 11/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.06 | General |
| Category: Cardiovascular | ||||||
| 09/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.53 | General |
| Category: Cardiovascular | ||||||
| 08/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: VACCINES | ||||||
| 06/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: Gastroenterology | ||||||
| 06/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Obesity | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Gastroenterology | ||||||
| 05/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| Category: Cardiovascular | ||||||
| 05/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 140 | 274 | $23,878 | $14,923 |
| 2022 | 6 | 133 | 250 | $22,556 | $13,972 |
| 2021 | 7 | 152 | 337 | $28,207 | $15,991 |
| 2020 | 6 | 134 | 296 | $24,255 | $11,815 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 67 | $10,452 | $6,132 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 53 | $5,724 | $3,465 | 60.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $3,520 | $2,709 | 77.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 32 | $2,080 | $1,328 | 63.9% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 13 | 29 | $1,392 | $691.36 | 49.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 37 | 71 | $710.00 | $596.40 | 84.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 66 | $10,296 | $5,911 | 57.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 60 | $6,480 | $4,089 | 63.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 20 | 20 | $3,200 | $2,529 | 79.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 28 | $1,820 | $1,222 | 67.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 35 | 62 | $620.00 | $173.03 | 27.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 14 | $140.00 | $48.25 | 34.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 78 | $12,168 | $6,674 | 54.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 56 | $6,048 | $3,140 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $3,040 | $2,457 | 80.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 43 | $2,795 | $1,664 | 59.5% |
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Office | 2021 | 13 | 52 | $2,496 | $1,177 | 47.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 11 | 11 | $880.00 | $652.60 | 74.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 37 | 78 | $780.00 | $225.95 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 93 | $14,508 | $6,692 | 46.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 49 | $5,292 | $2,815 | 53.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $1,760 | $1,243 | 70.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 23 | $1,495 | $693.02 | 46.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 38 | 94 | $940.00 | $280.74 | 29.9% |
| 81002 | Urinalysis, manual test | Office | 2020 | 13 | 26 | $260.00 | $90.34 | 34.7% |
About Dr. Bruce Bashline, DO
Dr. Bruce Bashline, DO is a Family Medicine healthcare provider based in Middletown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912015132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Bashline, DO has received a total of $6,876 in payments from pharmaceutical and medical device companies, with $715.99 received in 2024. These payments were reported across 449 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,845).
As a Medicare-enrolled provider, Bashline has provided services to 559 Medicare beneficiaries, totaling 1,157 services with total Medicare billing of $56,701. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Middletown, PA
- Active Since 08/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1912015132
Products in Payments
- XIFAXAN (Drug) $794.14
- TRULICITY (Drug) $380.63
- Ozempic (Drug) $296.68
- VRAYLAR (Drug) $252.22
- UBRELVY (Drug) $238.82
- Creon (Drug) $224.35
- QULIPTA (Drug) $221.14
- EMGALITY (Drug) $205.17
- TRELEGY ELLIPTA (Drug) $200.80
- Wegovy (Drug) $188.39
- Victoza (Drug) $175.91
- NURTEC ODT (Drug) $172.41
- LINZESS (Drug) $167.72
- ANORO (Drug) $163.49
- Vascepa (Drug) $157.35
- Aimovig (Biological) $151.56
- CREON (Drug) $147.21
- JARDIANCE (Drug) $137.12
- MIGRANAL (Drug) $136.01
- BASAGLAR (Drug) $125.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Middletown
Dr. Jagruti Gohel, Md, MD
Family Medicine — Payments: $22,313
Jenny Lu, Md, MD
Family Medicine — Payments: $17,128
Julia Ritsan, D.o, D.O
Family Medicine — Payments: $10,176
David Dornfeld, Do, DO
Family Medicine — Payments: $8,861
Katherine Schneider, M.d, M.D
Family Medicine — Payments: $7,970
Karen Warner, M.d, M.D
Family Medicine — Payments: $7,355